Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer a methodological protocol to a study using five European databases - Archive ouverte HAL Access content directly
Journal Articles Fundamental & Clinical Pharmacology Year : 2019

Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer a methodological protocol to a study using five European databases

Fichier principal
Vignette du fichier
George_et_al-2019-Real‐world insights into risk of developing cardiovascular disease.pdf (1.08 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

hal-02055724 , version 1 (17-04-2019)

Licence

Attribution - NonCommercial - NoDerivatives - CC BY 4.0

Identifiers

Cite

Gincy George, Lucie-Marie Scailteux, Hans Garmo, Frédéric Balusson, Christopher Cardwell, et al.. Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer a methodological protocol to a study using five European databases. Fundamental & Clinical Pharmacology, 2019, 33 (4), pp.479-499. ⟨10.1111/fcp.12454⟩. ⟨hal-02055724⟩
73 View
60 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More